Abstract
Understanding the molecular mechanisms of insulin resistance remains a major medical challenge of the twenty-first century. Over the last half-century, many hypotheses have been proposed to explain insulin resistance, and, most recently, inflammation associated with alterations in adipocytokines has become the prevailing hypothesis. Here we discuss diacylglycerol-mediated insulin resistance as an alternative and unifying hypothesis to explain the most common forms of insulin resistance associated with obesity and type 2 diabetes mellitus, as well as lipodystrophy and aging.
References
International Diabetes Federation. http://www.idf.org/latest-diabetes-figures-paint-grim-global-picture/ (2009).
Shulman, G.I. et al. N. Engl. J. Med. 322, 223–228 (1990).
Cline, G.W. et al. N. Engl. J. Med. 341, 240–246 (1999).
Rothman, D.L., Shulman, R.G. & Shulman, G.I. J. Clin. Invest. 89, 1069–1075 (1992).
Magnusson, I., Rothman, D.L., Katz, L.D., Shulman, R.G. & Shulman, G.I. J. Clin. Invest. 90, 1323–1327 (1992).
Roden, M. et al. Diabetes 49, 701–707 (2000).
Landau, B.R. et al. J. Clin. Invest. 98, 378–385 (1996).
Yalow, R.S. & Berson, S.A. J. Clin. Invest. 39, 1157–1175 (1960).
Schenk, S., Saberi, M. & Olefsky, J.M. J. Clin. Invest. 118, 2992–3002 (2008).
Shoelson, S.E., Lee, J. & Goldfine, A.B. J. Clin. Invest. 116, 1793–1801 (2006).
Hotamisligil, G.S. Nature 444, 860–867 (2006).
Hotamisligil, G.S. Int. J. Obes. (Lond.) 32 Suppl 7, S52–S54 (2008).
Evans, J.L., Goldfine, I.D., Maddux, B.A. & Grodsky, G.M. Endocr. Rev. 23, 599–622 (2002).
Kulkarni, R.N. et al. Cell 96, 329–339 (1999).
Brüning, J.C. et al. Cell 88, 561–572 (1997).
Randle, P.J., Garland, P.B., Hales, C.N. & Newsholme, E.A. Lancet 1, 785–789 (1963).
Randle, P.J., Newsholme, E.A. & Garland, P.B. Biochem. J. 93, 652–665 (1964).
Randle, P.J., Garland, P.B., Newsholme, E.A. & Hales, C.N. Ann. NY Acad. Sci. 131, 324–333 (1965).
Roden, M. et al. J. Clin. Invest. 97, 2859–2865 (1996).
Dresner, A. et al. J. Clin. Invest. 103, 253–259 (1999).
Yu, C. et al. J. Biol. Chem. 277, 50230–50236 (2002).
Griffin, M.E. et al. Diabetes 48, 1270–1274 (1999).
Itani, S.I., Ruderman, N.B., Schmieder, F. & Boden, G. Diabetes 51, 2005–2011 (2002).
Kim, J.K. et al. Proc. Natl. Acad. Sci. USA 98, 7522–7527 (2001).
Kim, J.K. et al. J. Clin. Invest. 113, 756–763 (2004).
Liu, L. et al. J. Clin. Invest. 117, 1679–1689 (2007).
Choi, C.S. et al. J. Clin. Invest. 117, 1995–2003 (2007).
Choi, C.S. et al. Proc. Natl. Acad. Sci. USA 104, 16480–16485 (2007).
Kim, J.K. et al. J. Clin. Invest. 114, 823–827 (2004).
Hoehn, K.L. et al. Cell Metab. 11, 70–76 (2010).
Samuel, V.T. et al. J. Biol. Chem. 279, 32345–32353 (2004).
Samuel, V.T. et al. J. Clin. Invest. 117, 739–745 (2007).
Nagai, Y. et al. Cell Metab. 9, 252–264 (2009).
Neschen, S. et al. Cell Metab. 2, 55–65 (2005).
Choi, C.S. et al. J. Biol. Chem. 282, 22678–22688 (2007).
Savage, D.B. et al. J. Clin. Invest. 116, 817–824 (2006).
Zhang, D. et al. Proc. Natl. Acad. Sci. USA 104, 17075–17080 (2007).
Weiss, R. et al. Lancet 362, 951–957 (2003).
Petersen, K.F. et al. J. Clin. Invest. 109, 1345–1350 (2002).
Luzi, L. et al. Am. J. Physiol. Endocrinol. Metab. 284, E274–E280 (2003).
Morino, K. et al. J. Clin. Invest. 115, 3587–3593 (2005).
Befroy, D.E. et al. Diabetes 56, 1376–1381 (2007).
Petersen, K.F. et al. Science 300, 1140–1142 (2003).
Chibalin, A.V. et al. Cell 132, 375–386 (2008).
Petersen, K.F. et al. N. Engl. J. Med. 362, 1082–1089 (2009).
Weisberg, S.P. et al. J. Clin. Invest. 112, 1796–1808 (2003).
Xu, H. et al. J. Clin. Invest. 112, 1821–1830 (2003).
Taubes, G. Science 325, 256–260 (2009).
Petersen, K.F., Dufour, S., Befroy, D., Garcia, R. & Shulman, G.I. N. Engl. J. Med. 350, 664–671 (2004).
Kim, J.K., Gavrilova, O., Chen, Y., Reitman, M.L. & Shulman, G.I. J. Biol. Chem. 275, 8456–8460 (2000).
Petersen, K.F. et al. Diabetes 54, 603–608 (2005).
Pedersen, B.K. & Febbraio, M.A. J. Appl. Physiol. 102, 814–816 (2007).
Shoelson, S.E. J. Appl. Physiol. 102, 820 (2007).
Ofei, F., Hurel, S., Newkirk, J., Sopwith, M. & Taylor, R. Diabetes 45, 881–885 (1996).
Mayerson, A.B. et al. Diabetes 51, 797–802 (2002).
Belfort, R. et al. N. Engl. J. Med. 355, 2297–2307 (2006).
Neschen, S. et al. Diabetes 56, 1034–1041 (2007).
Kim, J.K. et al. Diabetes 52, 1311–1318 (2003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Erion, D., Shulman, G. Diacylglycerol-mediated insulin resistance. Nat Med 16, 400–402 (2010). https://doi.org/10.1038/nm0410-400
Issue Date:
DOI: https://doi.org/10.1038/nm0410-400
- Springer Nature America, Inc.
This article is cited by
-
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies
Scientific Reports (2023)
-
Metabolome-wide association study on physical activity
Scientific Reports (2023)
-
Postpartum plasma metabolomic profile among women with preeclampsia and preterm delivery: implications for long-term health
BMC Medicine (2020)
-
Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease
Lipids in Health and Disease (2020)
-
Generation of immune cell containing adipose organoids for in vitro analysis of immune metabolism
Scientific Reports (2020)